-
1
المؤلفون: Pentheroudakis, George, Pavlidis, Nicholas
المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961], Pentheroudakis, George [0000-0002-6632-2462]
المصدر: Expert opinion on pharmacotherapy
مصطلحات موضوعية: Drug dose regimen, Oncology, Hydrocortisone, Carcinogenesis, Life expectancy, medicine.medical_treatment, Dermatitis, Review, Antipyretic agent, Diagnostic accuracy, Dna topoisomerases, Breast cancer, Leukoencephalopathy, Antineoplastic agents, Meningeal Neoplasms, Pharmacology (medical), Enzyme Inhibitors, Cerebrospinal fluid analysis, Injections, Spinal, Adenocarcinoma/pathology, Enzyme Inhibitors/therapeutic use, Palliative Care, Headache, General Medicine, Prognosis, Antineoplastic, Alkylating, Management, Arachnoid Cysts, Clinical trial, Nuclear magnetic resonance imaging, Spinal cord disease, Randomized controlled trials, Reverse transcription polymerase chain reaction, fluid/therapeutic use, Topotecan/therapeutic use, Rituximab, Lymphoma/pathology, Human, Antimetabolites, Antineoplastic, medicine.medical_specialty, Leptomeninx, Bone marrow suppression, Vomiting, Leptomeningeal, Adenocarcinoma, Irinotecan, Beta 2 microglobulin, Disease association, Drug formulation, Meningism, Humans, Combined Modality Therapy, Molecular mechanics, Antineoplastic Agents, Alkylating, High risk population, Steroid, Pharmacology, Carcinoma/*drug therapy/radiotherapy/secondary, Type i, medicine.disease, Lymphoma, Radiation therapy, Myelin basic protein, Methotrexate, Arachnoiditis, Delayed-Action Preparations, Laboratory diagnosis, Risk factor, Topoisomerase I Inhibitors, Palliative care, Antimetabolites, Meningeal Neoplasms/*drug therapy/radiotherapy/secondary, Dexamethasone, Cancer risk, Arachnoid cysts, Photophobia, Thiotepa/administration & dosage/cerebrospinal fluid/therapeutic use, Nephrotoxicity, Randomized Controlled Trials as Topic, Meningeal metastasis, Leukemia, Cytarabine, Folinic acid, Lactate dehydrogenase, Nausea, Combined modality therapy, Enzyme inhibitors, Antineoplastic Agents, Alkylating/administration & dosage/cerebrospinal, Sensitivity and specificity, Cranial irradiation, Injections, Intravenous, Cytarabine/administration & dosage/cerebrospinal fluid/therapeutic use, Meningeal neoplasms, Mafosfamide, Intravenous, Carcinomatous meningitis, Algorithms, Drug elimination, Fever, Spinal, Liver toxicity, Drug response, Cerebellum disease, Arachnoid Cysts/*drug therapy/etiology/radiotherapy, Drug half life, Neuroimaging, Malignancy, Injections, Methotrexate/administration & dosage/cerebrospinal fluid/therapeutic use, Aseptic meningitis, Mucosa inflammation, Internal medicine, Computer assisted tomography, Temozolomide, medicine, Leukemia/pathology, Antimetabolites, Antineoplastic/administration & dosage/cerebrospinal, Vasculotropin, Performance status, business.industry, Carcinoma, Trastuzumab, Cancer survival, Surgery, Drug efficacy, Carcinoembryonic antigen, Delayed-action preparations, Cranial Irradiation, Antiemetic agent, Topotecan, Cytology, business, Thiotepa
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::833bf06fd03c56e21514d92c7baec460Test
https://doi.org/10.1517/14656566.6.7.1115Test -
2
المؤلفون: Francesco Ricciuti, Maria Concetta Petti, Felicetto Ferrara, Eugenio Gallo, Eros Di Bona, Rosangela Invernizzi, Francesco Lo-Coco, M. L. Vegna, Sergio Amadori, Mario Lazzarino, Giuseppe Avvisati, Guglielmo Mariani, Simona Sica, Franco Mandelli, Nicola Cantore, Carmine Selleri, Giuseppe Fioritoni, Dino Veneri, Vincenzo Liso, Michele Baccarani
المصدر: Blood. 100:3141-3146
مصطلحات موضوعية: Male, leukocyte count, vomiting, medicine.medical_treatment, diarrhea, heart failure, idarubicin, Biochemistry, Gastroenterology, Hepatitis, law.invention, Leukemia, Promyelocytic, Acute, Randomized controlled trial, cytarabine, Antibiotics, law, cancer diagnosis, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Medicine, promyelocytic leukemia, cancer survival, Child, Promyelocytic, Antibiotics, Antineoplastic, Leukemia, adult, Remission Induction, article, Age Factors, clinical trial, Hematology, Middle Aged, Antineoplastic, Chemotherapy regimen, female, multivariate analysis, Treatment Outcome, priority journal, cancer regression, monotherapy, drug induced disease, mucosa inflammation, Chemical and Drug Induced Liver Injury, Infection, mercaptopurine, methotrexate, tioguanine, bleeding, cancer combination chemotherapy, controlled clinical trial, controlled study, drug infusion, follow up, human, infection, kidney failure, liver failure, major clinical study, male, multicenter study, randomized controlled trial, survival time, 6-Mercaptopurine, Adolescent, Adult, Cytarabine, Disease-Free Survival, Female, Follow-Up Studies, Hemorrhage, Hepatitis, Toxic, Humans, Idarubicin, Leukocyte Count, Methotrexate, Vomiting, medicine.drug, Acute promyelocytic leukemia, medicine.medical_specialty, Anthracycline, Immunology, Acute, Infections, Internal medicine, Chemotherapy, business.industry, Cell Biology, Toxic, medicine.disease, Surgery, business, Settore MED/15 - Malattie del Sangue
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d60a37d5f4ba5607eb18ed1ef5654059Test
https://doi.org/10.1182/blood-2002-02-0352Test -
3دورية أكاديمية
المساهمون: Pavlidis, Nicholas 0000-0002-2195-9961, Pentheroudakis, George 0000-0002-6632-2462, Boussios, Stergios 0000-0002-2512-6131
المصدر: Annals of Gastroenterology
مصطلحات موضوعية: Antineoplastic agent, Cisplatin, Cytarabine, Dacarbazine, Doxorubicin, Fluorouracil, Human, Methotrexate, Patient care, Procarbazine, Carboplatin, Chemotherapy, Abdominal pain, Anorexia, Bone marrow suppression, Constipation, Diarrhea, Drug efficacy, Mucosa inflammation, Nausea and vomiting, Ondansetron, Oxaliplatin, Stomatitis, Taxane derivative, Review, Erlotinib, Imatinib, Unindexed drug, Gastrointestinal symptom, Incidence
-
4
المؤلفون: Fountzilas, George, Dafni, U., Papadimitriou, C., Timotheadou, E., Gogas, H., Eleftheraki, A. G., Xanthakis, I., Christodoulou, C., Koutras, A. K., Papandreou, C. N., Papakostas, P., Miliaras, S., Markopoulos, C., Dimitrakakis, C., Korantzopoulos, Panagiotis, Karanikiotis, C., Bafaloukos, Dimitrios, Kosmidis, Paraskevas A., Samantas, E., Varthalitis, I., Pavlidis, Nicholas, Pectasides, Dimitrios, Dimopoulos, M. A.
المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961]
المصدر: BMC Cancer
مصطلحات موضوعية: Oncology, Survival rate, Neurologic disease, Docetaxel, Skin disease, Multiple cycle treatment, Eye disease, Breast cancer, Phase 3 clinical trial, Antineoplastic agents, Antineoplastic Combined Chemotherapy Protocols, Pathology, Drug fatality, Anthracyclines, Disease free survival, Open study, Fulvestrant, Mastectomy, Dose-dense sequential chemotherapy, Multicenter study, Clinical trial, Antineoplastic agent, Randomized controlled trial, Granulocyte colony stimulating factor, Goserelin, Thrombocyte, Infection, Human, Diarrhea, medicine.medical_specialty, Paclitaxel, Vomiting, Febrile neutropenia, Heart failure, Antineoplastic Agents, Major clinical study, Side effect, Heart disease, Anastrozole, Vascular disease, Article, Disease-Free Survival, Drug Administration Schedule, Epidermal growth factor receptor 2, Taxanes, Median follow-up, Genetics, Humans, Hemoglobin, Phase 3 clinical trial (topic), Cyclophosphamide, Aged, Follow up, Leukopenia, Myalgia, medicine.disease, Metabolic disorder, Cancer combination chemotherapy, Regimen, Tamoxifen, Methotrexate, Cancer adjuvant therapy, Asymptomatic disease, Comparative study, Breast neoplasms, Cancer Research, Partial mastectomy, Heart ejection fraction, Gonadorelin, Skin manifestation, Monoclonal, Edema, Overall survival, Middle aged, Humanized, Fatigue, Adjuvant, Drug withdrawal, Neutrophil, Nausea, Middle Aged, Gastrointestinal disease, Arthralgia, Anorexia, Chemotherapy, Adjuvant, Cancer radiotherapy, Female, Fluorouracil, Epirubicin, medicine.drug, Research Article, Monoclonal antibody, Adult, Neutropenia, Disease-free survival, Pain, Breast Neoplasms, Follow-up studies, Antibodies, Monoclonal, Humanized, Antibodies, Young Adult, Mucosa inflammation, Internal medicine, Antineoplastic combined chemotherapy protocols, medicine, Chemotherapy, Early cancer, Taxane, business.industry, Drug administration, Loading drug dose, Lymphocytopenia, Drug administration schedule, Allergic reaction, Patient compliance, Aromatase inhibitor, Leukocyte, Trastuzumab, Adjuvant chemotherapy, Drug efficacy, Young adult, Lung disease, business, Controlled study, Follow-Up Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86f05a4fb1c5cce316e6477713a4950eTest
https://pubmed.ncbi.nlm.nih.gov/25026897Test -
5
المؤلفون: O'Neil, Bert H.
المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Anabilim Dalı., Kanat, Özkan
مصطلحات موضوعية: Continuous infusion, Drug targeting, Survival rate, Cetuximab, Gimeracil plus oteracil potassium plus tegafur, Docetaxel, Review, Medical decision making, Treatment response, Metastasis, Gastroesophageal junction adenocarcinoma, Multiple cycle treatment, Randomized controlled trial (topic), Targeted treatment, Pathology, Drug fatality, Overall survival, Treatment outcome, Etoposide, Priority journal, Survival time, Drug tolerability, Panitumumab, Folinic acid, Anemia, Nausea, Immunohistochemistry, Esophagus cancer, Chemotherapy-naive patients, Bevacizumab, Oxaliplatin, Europe, Clinical trial (topic), Oncology, Antineoplastic agent, Decreased appetite, Molecularly targeted therapy, Drug dose reduction, Fluorouracil, Human, Diarrhea, Drug megadose, Quality of life, Asia, Neutropenia, Plus cisplatin, Stomach cancer, Febrile neutropenia, Drug delivery system, Antiangiogenic therapy, Hypokalemia, Cancer mortality, Cause of death, Stomach tumor, Irinotecan, Epidermal growth factor receptor 2, Targeted therapies, Stomach perforation, Mucosa inflammation, 1st-line treatment, Rash, Thromboembolism, Chemotherapy, Everolimus, Gene mutation, Phase 3 clinical trial (topic), Ramucirumab, Rivoceranib, Line, Capecitabine, Placebo, Epirubicin, Cancer prognosis, Stomatitis, Vasculotropin, Oncogene K ras, Vasculotropin receptor 1, Phase-II trial, Trastuzumab, Vasculotropin receptor 2, Monotherapy, Metastatic stomach cancer, Multicenter study (topic), Cancer survival, Cancer combination chemotherapy, Methotrexate, Clinical effectiveness, Acne, Doxorubicin, Progression free survival, Protein expression, Cisplatin, Gastric cancer, Prognostic model, Phase 2 clinical trial (topic), Phosphatidylinositol 3 kinase
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______9458::c357870bd9aace288f11f0f0c08d1514Test
http://hdl.handle.net/11452/27330Test -
6دورية أكاديمية
المؤلفون: Blink, M., Buitenkamp, T.D., Wouwe, J.P. van, Wering, E.R. van, Velden, V.H.J. van der, Zwaan, C.M.
المصدر: Tijdschrift voor Kindergeneeskunde, 2, 77, 52-58
مصطلحات موضوعية: Health, Cytostatic agent, Methotrexate, Acute granulocytic leukemia, Acute lymphoblastic leukemia, Acute lymphocytic leukemia, Cancer patient, Cancer survival, Clinical feature, Clinical protocol, Disease severity, Down syndrome, High risk patient, Human, Leukemia, Lymphoblast, Mucosa inflammation, Netherlands, Prognosis, Symptomatology, Treatment outcome, Unspecified side effect
العلاقة: uuid:dd059d8b-8e05-4937-b235-38cb159564ed; 241455; http://resolver.tudelft.nl/uuid:dd059d8b-8e05-4937-b235-38cb159564edTest
-
7
مصطلحات موضوعية: Leukemia, Down syndrome, Acute lymphocytic leukemia, Acute lymphoblastic leukemia, Unspecified side effect, Prognosis, Cancer survival, Acute granulocytic leukemia, High risk patient, Methotrexate, Clinical feature, Health, Mucosa inflammation, hemic and lymphatic diseases, Cancer patient, Clinical protocol, Lymphoblast, Symptomatology, Treatment outcome, Disease severity, Cytostatic agent, Human, Netherlands
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=dris___00893::5f6b3817e6d8d44a0e7fc68dd427c806Test
http://resolver.tudelft.nl/uuid:dd059d8b-8e05-4937-b235-38cb159564edTest -
8دورية أكاديمية
المؤلفون: Avvisati G., Petti M. C., Vegna M. L., Baccarani M., Cantore N., Bona E. D., Ferrara F., Fioritoni G., Gallo E., Invernizzi R., Lazzarino M., Liso V., Mariani G., Ricciuti F., Selleri C., Sica S., Veneri D., Mandelli F., LO COCO, FRANCESCO, AMADORI, SERGIO
المساهمون: Avvisati, G, Petti, Mc, LO COCO, F, Vegna, Ml, Amadori, S, Baccarani, M, Cantore, N, Bona, Ed, Ferrara, F, Fioritoni, G, Gallo, E, Invernizzi, R, Lazzarino, M, Liso, V, Mariani, G, Ricciuti, F, Selleri, C, Sica, S, Veneri, D, Mandelli, F
مصطلحات موضوعية: cytarabine, idarubicin, mercaptopurine, methotrexate, tioguanine, adult, article, bleeding, cancer combination chemotherapy, cancer diagnosi, cancer regression, cancer survival, clinical trial, controlled clinical trial, controlled study, diarrhea, drug induced disease, drug infusion, female, follow up, heart failure, human, infection, kidney failure, leukocyte count, liver failure, major clinical study, male, monotherapy, mucosa inflammation
العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000178822300014; volume:100; issue:9; firstpage:3141; lastpage:3146; journal:Blood; http://hdl.handle.net/2108/50982Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-0036838645
-
9
المؤلفون: Ender Kurt, Guzin Gonullu, Murat Arslan, Ozkan Kanat, Osman Manavoglu, Mutlu Demiray, Turkkan Evrensel, Murat Kiyici
المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Medikal Onkoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Gastroenteroloji Anabilim Dalı., Kanat, Özkan, Evrensel, Türkkan, Manavoğlu, Osman, Demiray, Mutlu, Kurt, Ender, Gönüllü, Güzin, Kıyıcı, Murat, Arslan, Murat, AAJ-1027-2021, M-8060-2019
المصدر: Tumori. 89(4)
مصطلحات موضوعية: Male, Cancer Research, ECOG Performance Status, Gastroenterology, Second-line chemotherapy, 030218 nuclear medicine & medical imaging, Carboplatin, 0302 clinical medicine, Drug safety, Liver metastasis, Survival time, Combination chemotherapy, Anemia, General Medicine, Middle Aged, Clinical trial, Lung metastasis, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Disease Progression, Female, Fluorouracil, medicine.drug, Human, Diarrhea, Adult, medicine.medical_specialty, Neutropenia, Paclitaxel, Mitomycin, Clinical article, Irinotecan, Loperamide, Article, 03 medical and health sciences, Mucosa inflammation, Stomach Neoplasms, Internal medicine, Advanced cancer, medicine, Peritoneum metastasis, Humans, Stomach carcinoma, Ramucirumab, Rivoceranib, Line, Survival analysis, Aged, Lymph node metastasis, business.industry, medicine.disease, Monotherapy, Thrombocytopenia, Antineoplastic Agents, Phytogenic, Survival Analysis, Surgery, Regimen, Drug efficacy, Methotrexate, Doxorubicin, Camptothecin, Phase-II, Cisplatin, business, Gastric cancer, Progressive disease, Supportive care
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15b6ef5b813b9cfb143106f84b52ba1cTest
https://pubmed.ncbi.nlm.nih.gov/14606644Test -
10دورية أكاديمية
المؤلفون: Muro, H., Acuña, L.R., Castagnari, A., Blajman, C., Schmilovich, A., Hidalgo, A., Fiori, H., Bader, M., Marantz, A.
مصطلحات موضوعية: allopurinol, doxorubicin, fluorouracil, folinic acid, methotrexate, adverse drug reaction, blood and hemopoietic system, bone marrow depression, cancer chemotherapy, cancer combination chemotherapy, clinical article, diarrhea, drug efficacy, drug therapy, gastrointestinal toxicity, human, intoxication, intravenous drug administration, mucosa inflammation, nausea, priority journal, stomach, stomach cancer, therapy, vomiting, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Female, Humans
